Search Results

Check out five New York companies hiring biopharma professionals like you, including 2025 Best Places to Work winners.

Common Shares to Begin Trading on Nasdaq on Tuesday, November 12, 2024

aTyr Pharma, Inc. announced that the Company will be changing its ticker symbol from “LIFE” to “ATYR.” Effective at the market open on June 5, 2024, the Company’s common stock will trade on the Nasdaq Capital Market under the new symbol “ATYR.”

TransCode Therapeutics, Inc. announced that it has received notice from the NASDAQ Stock Market LLC that the Nasdaq has determined that the Company has regained compliance with the minimum stockholders’ equity requirement under Nasdaq Listing Rule 5550 for continued listing on the Nasdaq Capital Market.

Microbot Medical Inc. announced that it has entered into definitive agreements for the purchase and sale of 1,566,669 shares of the Company’s common stock at a purchase price of $1.50 per share of common stock in a registered direct offering priced at-the-market under Nasdaq rules.

Reviva Pharmaceuticals Holdings, Inc. announced that it has entered into a definitive agreement for the sale and issuance of 1,898,734 shares of the Company’s common stock and warrants to purchase up to 1,898,734 shares of common stock at a combined offering price of $1.58 per share of common stock and accompanying warrant in a registered direct offering priced at-the-market under the Nasdaq rules.